Versigent director granted 14.65 dividend rights

Versigent director Kevin P. Clark received 14.65 dividend-equivalent rights tied to existing RSU grants following a company dividend.

Available on EDGAR 09/22/2026 - 04:09 PM EDT Accepted by SEC EDGAR 09/22/2026 - 04:09 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Versigent PLC (VGNT) director Kevin P. Clark reported an acquisition of 14.65 Dividend Equivalent Rights on September 18, 2026. These derivative rights accrued on prior restricted stock unit grants due to a dividend declared and paid by Versigent and represent the economic equivalent of 14.65 ordinary shares, vesting on the same schedule as the related RSUs.

Insider Trade Summary

Grant/Award: 14.65 shares

Grant/Award 1 txn

Insider CLARK KEVIN P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Dividend Equivalent Rights F1	14.65	$0.00	$0.00

Holdings After Transaction: Dividend Equivalent Rights — 14.65 rights (Direct)

Holdings Before and After: Dividend Equivalent Rights, 0 to 14.65 rights (Direct)

Footnotes (1)

1. F1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.

Key Figures

Dividend Equivalent Rights acquired: 14.65 rights Price per Dividend Equivalent Right: $0.00 Dividend Equivalent Rights held after transaction: 14.65 rights +1 more

4 metrics

Dividend Equivalent Rights acquired 14.65 rights Grant/award acquisition on September 18, 2026

Price per Dividend Equivalent Right $0.00 Grant/award acquisition on September 18, 2026

Dividend Equivalent Rights held after transaction 14.65 rights Total derivative holdings from this award following the reported transaction

Underlying ordinary shares equivalent 14.65 shares Each Dividend Equivalent Right equals one Versigent ordinary share economically

Key Terms

Dividend Equivalent Rights, restricted stock units, ordinary shares

3 terms

Dividend Equivalent Rights financial

"The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock units financial

"The dividend equivalent rights accrued on grants of restricted stock units as a result"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

ordinary shares financial

"Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did VGNT director Kevin P. Clark report?

He reported an acquisition of 14.65 Dividend Equivalent Rights on September 18, 2026. These rights arose from a Versigent dividend on previously granted restricted stock units and are economically equivalent to 14.65 ordinary shares, vesting with the underlying RSUs.

Did Versigent (VGNT) director Clark buy or sell shares on the market?

No. The Form 4 shows a grant/award acquisition of 14.65 Dividend Equivalent Rights at a price of $0.00 per right, arising from a dividend on existing RSUs, rather than an open-market purchase or sale of Versigent ordinary shares.

What are the Dividend Equivalent Rights reported for VGNT?

They are Dividend Equivalent Rights that accrued on restricted stock units because Versigent declared and paid a dividend. Each right is the economic equivalent of one ordinary share and will vest on the same schedule as the related restricted stock units.

How many Versigent-equivalent shares does Kevin P. Clark now hold from this award?

Following the transaction, he holds 14.65 Dividend Equivalent Rights, each equal in economic value to one Versigent ordinary share, for a total economic equivalent of 14.65 ordinary shares tied to this specific award.

Was a Rule 10b5-1 trading plan involved in this VGNT Form 4?

No. The filing indicates the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the transaction was executed under a Rule 10b5-1 or other pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CLARK KEVIN P

(Last) (First) (Middle)

SPITALSTRASSE 5,

(Street)

SCHAFFHAUSEN 8200

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
Versigent PLC [ VGNT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Dividend Equivalent Rights	(1)	09/18/2026		A		14.65		(1)	(1)	Ordinary Shares	14.65	$0.00	14.65	D

Explanation of Responses:

1. The dividend equivalent rights accrued on grants of restricted stock units as a result of a dividend declared and paid by the issuer. These rights vest on the same schedule as the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of the issuer's ordinary shares.

	/s/ Janis N. Acosta, Attorney-in-fact for Kevin P. Clark	09/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)